Tumor rejection antigens presented by hla-b44 molecules, and...

Details Tumor rejection antigens presented by hla-b44 molecules, and... Tumor rejection antigens presented by hla-b44 molecules, and...

C - Chemistry, Metallurgy

07

K

C07K 7/06 (2006.01) A61K 35/14 (2006.01) C07K 14/47 (2006.01) C07K 14/74 (2006.01) G01N 33/554 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2232325

Tumor rejection antigens presented by HLA-B44 molecules are described. These peptides are useful in diagnostic and therapeutic methodologies. The tumor rejection antigens are not derived from tyrosinase, which has previously been identified as a tumor rejection antigen precursor processed to an antigen presented by HLA-B44.

L'invention porte sur des antigènes de rejet de tumeurs présentés par des molécules HLA-B44. Ces peptides s'avèrent utiles dans des méthodologies à caractère diagnostique ou thérapeutique. Lesdits antigènes ne sont pas dérivés de la tyrosinase antérieurement identifiée comme étant le précurseur d'un antigène de rejet de tumeurs traité pour donner l'antigène présenté par le HLA-B44.

Affiliated with

Also associated with

Rating

Tumor rejection antigens presented by hla-b44 molecules, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor rejection antigens presented by hla-b44 molecules, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor rejection antigens presented by hla-b44 molecules, and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1455937